SVA Share Price

Open 0.26 Change Price %
High 0.26 1 Day 0.00 0.00
Low 0.25 1 Week 0.00 0.00
Close 0.26 1 Month 0.08 44.44
Volume 61100 1 Year 0.00 0.00
52 Week High 0.32
52 Week Low 0.14
SVA Important Levels
Resistance 2 0.27
Resistance 1 0.27
Pivot 0.26
Support 1 0.25
Support 2 0.25
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PUM 0.11 37.50%
PUM 0.11 37.50%
GLK 0.06 50.00%
GLK 0.06 50.00%
COD 0.07 0.00%
COD 0.07 0.00%
More..
CVE Canada Top Gainers Stocks
SHL 0.02 100.00%
SHL 0.02 100.00%
SHL 0.02 100.00%
TYE 0.02 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
BXR 0.02 100.00%
CAP 0.02 100.00%
More..
CVE Canada Top Losers Stocks
KLM 0.01 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
GNT 0.13 -35.00%
More..

Sernova Corp (CVE: SVA)

SVA Technical Analysis 4
As on 31st Oct 2017 SVA Share Price closed @ 0.26 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.23 & Strong Buy for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for November
1st Target up-side 0.33
2nd Target up-side 0.37
3rd Target up-side 0.42
1st Target down-side 0.19
2nd Target down-side 0.15
3rd Target down-side 0.1
SVA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sernova.com
SVA Address
SVA
700 Collip Circle
Suite 114
London, ON N6G 4X8
Canada
Phone: 519-858-5184
Fax: 519-858-5099
SVA Latest News
Interactive Technical Analysis Chart Sernova Corp ( SVA CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sernova Corp
SVA Business Profile
Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.